"Nashville, Tennessee â€” Rapid endovascular treatment improved functional outcomes and halved mortality in ischemic stroke patients with a proximal vessel occlusion in the ESCAPE trial.
The study was presented at the International Stroke Co"...
Kit for the Preparation of Technetium Tc99m Exametazime Injection Diagnostic Radiopharmaceutical for Intravenous Use Only
The Ceretec kit is supplied as a pack of 5 vials for use in the preparation of a technetium Tc99m exametazime intravenous injection as a diagnostic radiopharmaceutical for use as an adjunct in the detection of altered regional cerebral perfusion and for the radiolabeling of autologous leukocytes. Each vial of Ceretec contains a pre-dispensed sterile, nonpyrogenic, lyophilized mixture of 0.5 mg exametazime [(RR,SS)-4.8-diaza-3,6,6,9-tetramethylundecane-2, 10-dione bisoxime], 7.6 μg stannous chloride dihydrate (minimum stannous tin 0.6 μg; maximum total stannous and stannic tin 4.0 μg per vial) and 4.5 mg sodium chloride, sealed under nitrogen atmosphere with a rubber closure. The product contains no antimicrobial preservative.
Prior to publication of the USAN, exametazime was formerly known as hexamethylpropylene amine oxime (HM-PAO). The name HM-PAO appears in many publications.
The structural formula of exametazime is:
When sterile pyrogen-free sodium pertechnetate Tc99m in isotonic saline is added to the vial of Ceretec, a Tc99m complex of exametazime is formed.
Administration is by intravenous injection for diagnostic use.
Technetium Tc99m decays by isomeric transition with a physical half-life of 6.03 hours.1 Photons that are useful for imaging studies are listed in Table 1.
Table 1: Principal Radiation Emission Data-technetium
|Radiation||Mean %/ Disintegration||Mean Energy (keV)|
1Dillman, L.T. and Von der Lage, F.C. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. MIRD Phamphlet No. 10, p. 62, 1975.
The specific gamma ray constant for technetium Tc99m is 206 microCoulomb kg-1/37 MBq-h, (0.8 R/millicurie-h) at 1 cm. The first half-value thickness of lead (Pb) for technetium Tc99m is 0.2 mm. A range of values for the relative attenuation of the radiation emitted by this radionuclide that results from interposition of various thicknesses of Pb is shown in Table 2. For example, the use of a 2.7 mm thickness of Pb will decrease the external radiation exposure by a factor of 1,000.
Table 2: Radiation Attenuation by Lead Shielding
|Shield Thickness (Pb) mm||Coefficient of Attenuation|
To correct for physical decay of this radionuclide, the fractions that remain at selected intervals relative to the time of calibration are shown in Table 3.
Table 3: Physical Decay
Chart – Tc99m half-life 6.03 hours
|Fraction Hours||Remaining||Fraction Hours||Remaining|
|*Calibration time (time of preparation)|
Last reviewed on RxList: 8/14/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Ceretec Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.